{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:30:49Z","timestamp":1790811049454,"version":"4.1.0"},"reference-count":41,"publisher":"Oceanside Publications Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Infectious diseases are a leading cause of morbidity and mortality worldwide. As of 2018, the total world population of children &lt; 5 years of age was roughly estimated at 679 million. Of these children, an estimated 5.3 million died of all causes in 2018, with\n an estimated 700,000 who died of vaccine-preventable infectious diseases; 99% of the children who died had lived in low- and middle-income countries. The infectious diseases that remain major causes of mortality for which vaccines have been shown to provide proven preventive success include,\n in order of prevalence, are those caused by Streptococcus pneumoniae, Rotavirus, Bordetella pertussis, measles virus, Haemophilus influenzae type b and influenza virus.\n                    <jats:bold>Objective:<\/jats:bold>\n                    The purpose of the present report was to address the global burden of these six vaccine-preventable\n infectious diseases in children &lt; 5 years of age, together with implications for the prevention of coronavirus disease 2019 (COVID-19) infection in children.\n                    <jats:bold>Methods:<\/jats:bold>\n                    The current immunization strategies for the prevention of the six vaccine-preventable infectious diseases\n in children are reviewed as a framework for new strategies of vaccine prevention of COVID-19 in children.\n                    <jats:bold>Results:<\/jats:bold>\n                    The burden of addressing vaccine prevention of future infectious disease in children can be effectively pursued through knowledge gained from past experiences\n with vaccine usage in these six vaccine-preventable childhood infectious diseases.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Issues with regard to the burden of disease mortality, disease transmission, and available vaccines as well as vaccine successes and shortcomings for specific pathogens can serve\n as important landmarks for effective use of future vaccines. Although much success has been made globally in preventing these childhood deaths, much remains to be done.\n                  <\/jats:p>","DOI":"10.2500\/aap.2021.42.210065","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T12:52:36Z","timestamp":1630932756000},"page":"378-385","source":"Crossref","is-referenced-by-count":124,"title":["The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?"],"prefix":"10.2500","volume":"42","author":[{"given":"Lawrence D.","family":"Frenkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anai.2016.04.015","article-title":"Bellanti, MD, FAAP, FACAAI, FAAAAI","volume":"117","author":"Frenkel","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B2","first-page":"14","article-title":"Infectious diseases as a cause of global childhood mortality and morbidity: Progress in recognition, prevention, and treatment","volume":"5","author":"Frenkel","journal-title":"Adv Pediatr Res"},{"key":"B3","article-title":"Levels and Trends in Child Mortality Report 2019","author":"Lucia","journal-title":"UNICEF"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0976-9668.127275","article-title":"Acute respiratory infections among under-5 children in India: a situational analysis","volume":"5","author":"Selvaraj","year":"2014","journal-title":"J Nat Sci Biol Med"},{"key":"B6","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1016\/S2214-109X(18)30274-2","article-title":"Pneumococcal and Haemophilus influenzae type b disease: moving numbers in the right direction","volume":"6","author":"Whitney","year":"2018","journal-title":"Lancet Glob Health"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22341.1","article-title":"Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections","volume":"9","author":"Feldman","year":"2020","journal-title":"F1000Res"},{"key":"B8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4161\/hv.34364","article-title":"Pertussis","volume":"11","author":"Gabutti","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B9","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/cid\/ciw550","article-title":"Pertussis in young infants throughout the world","volume":"63","author":"Cherry","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/jit639","article-title":"Pertussis pathogenesis\u2013what we know and what we don't know","volume":"209","author":"Hewlett","year":"2014","journal-title":"J Infect Dis"},{"key":"B11","first-page":"13","article-title":"The underappreciated need for maternal and neonatal immunization: call to action","volume":"1","author":"Frenkel","year":"2019","journal-title":"O J Gyn Obstet Res"},{"key":"B12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00431-013-2023-6","article-title":"The burden of seasonal and pandemic influenza in infants and children","volume":"173","author":"Ruf","year":"2014","journal-title":"Eur J Pediatr"},{"key":"B14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(05)70270-X","article-title":"Understanding the symptoms of the common cold and influenza","volume":"5","author":"Eccles","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"B15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/humrep\/det455","article-title":"Influenza and congenital anomalies: a systematic review and meta-analysis","volume":"29","author":"Luteijn","year":"2014","journal-title":"Hum Reprod"},{"key":"B16","first-page":"725","article-title":"Vaccination against influenza","volume":"8","author":"Francis","year":"1953","journal-title":"Bull World Health Organ"},{"key":"B17","doi-asserted-by":"crossref","first-page":"D10","DOI":"10.1016\/j.vaccine.2008.06.083","article-title":"Safety and efficacy of live attenuated influenza vaccine in children 2\u20137 years of age","volume":"26","author":"Belshe","year":"2008","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"crossref","first-page":"e20183290","DOI":"10.1542\/peds.2018-3290","article-title":"Live attenuated influenza vaccine: will the Phoenix rise again?","volume":"143","author":"Piedra","year":"2019","journal-title":"Pediatrics"},{"key":"B19","doi-asserted-by":"crossref","first-page":"e20182094","DOI":"10.1542\/peds.2018-2094","article-title":"Live attenuated and inactivated influenza vaccine effectiveness","volume":"143","author":"Chung","year":"2019","journal-title":"Pediatrics"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2020\u201321 influenza season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"B21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2051013615595595","article-title":"Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults","volume":"3","author":"Cox","year":"2015","journal-title":"Ther Adv Vaccines"},{"key":"B22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4684-1012-9_6","article-title":"Immunology of measles, mumps, and rubella viruses","volume-title":"Immunology of Human Infection","author":"Frenkel","year":"1982"},{"key":"B23","article-title":"Worldwide measles deaths climb 50% from 2016 to 2019 claiming over 207 500 lives in 2019 12 November 2020 WHO"},{"key":"B24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"Retracted article. Ileal lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1503\/cmaj.109-3179","article-title":"Lancet retracts 12-year-old article linking autism to MMR vaccines","volume":"182","author":"Eggertson","year":"2010","journal-title":"CMAJ"},{"key":"B26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2019.8251","article-title":"Outbreaks of vaccine-preventable diseases responding to system failure with national vaccination requirements","volume":"322","author":"Davis","year":"2019","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jama.2014.16286","article-title":"Legislative prescriptions for controlling nonmedical vaccine exemptions","volume":"313","author":"Yang","year":"2015","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children <5 years of age","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B29","doi-asserted-by":"crossref","first-page":"e67763","DOI":"10.1371\/journal.pone.0067763","article-title":"Household transmission of rotavirus in a community with rotavirus vaccination in Quininde, Ecuador","volume":"8","author":"Lopman","year":"2013","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2217\/fvl-2016-0082","article-title":"Rotavirus vaccines: current global impact and future perspectives","volume":"11","author":"Burnett","year":"2016","journal-title":"Future Virol"},{"key":"B31","article-title":"Immunization coverage"},{"key":"B32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/infdis\/jiv398","article-title":"Rapid declines in age group-specific rotavirus infection and acute gastroenteritis among vaccinated and unvaccinated individuals within 1 year of rotavirus vaccine introduction in England and Wales","volume":"213","author":"Atchison","year":"2016","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"crossref","first-page":"e41720","DOI":"10.1371\/journal.pone.0041720","article-title":"Understanding reduced rotavirus vaccine efficacy in low socio-economic settings","volume":"7","author":"Lopman","year":"2012","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/pathogens6040065","article-title":"Differences of rotavirus vaccine effectiveness by country: likely causes and contributing factors","volume":"6","author":"Desselberger","year":"2017","journal-title":"Pathogens"},{"key":"B35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2500\/aap.2021.42.200104","article-title":"COVID-19 in children: pathogenesis and current status","volume":"42","author":"Frenkel","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1016\/j.vaccine.2020.10.068","article-title":"A clinical perspective of the U.S. anti-vaccination epidemic: considering marginal costs and benefits, CDC best practices guidelines, free riders, and herd immunity","volume":"38","author":"Anderson","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2500\/aap.2021.42.200116","article-title":"COVID-19 vaccines and vaccine hesitancy: role of the allergist\/immunologist in promotion of vaccine acceptance","volume":"42","author":"Bellanti","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"B39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.15585\/mmwr.mm6919e2","article-title":"Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration - United States, 2020","volume":"69","author":"Santoli","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"pt B","key":"B41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.imlet.2014.06.006","article-title":"Immunosenescence and vaccine failure in the elderly: strategies for improving response","volume":"162","author":"Boraschi","year":"2014","journal-title":"Immunol Lett"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2021\/00000042\/00000005\/art00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T12:54:41Z","timestamp":1630932881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2021.42.210065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,1]]}},"alternative-id":["1088-5412(20210901)42:5L.378;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2021.42.210065","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}